2022
DOI: 10.1093/ajh/hpac062
|View full text |Cite
|
Sign up to set email alerts
|

Telmisartan Reduces Atrial Fibrillation Susceptibility in Pressure Overload Rats and Its Molecular Mechanism Based on Gene Sequencing

Abstract: Background To assess the effects of telmisartan on susceptibility of atrial fibrillation (AF) in pressure overload rats, and to probe the underlying molecular mechanism and signal pathways. Methods Forty-nine 12-week-old male SD rats were randomly divided into sham operation (n = 15), abdominal aorta coarctation (AAC, n = 17), and AAC with telmisartan treatment groups (n = 17). Telmisartan 10 mg/(kg d) was administered by gav… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles